April 18, 2018
Ultragenyx Pharmaceutical’s Crysvita first FDA-approved medication for the treatment of XLH
The U.S. Food and Drug Administration has approved Ultragenyx Pharmaceutical’s Crysvita (burosumab), the first drug approved to treat adults and children ages…